Managing Severe COVID-19 in the Hospital Setting: An Interprofessional Approach

Program Overview

“I was dying … and I was dying alone,” says Nancy, recalling her lonely isolation in the intensive care unit as one of the earlier victims of COVID-19 in her region. This dynamic panel features an interprofessional lineup of experts who will debate and discuss data, guidelines, and literature on the treatment of severe COVID-19 in the hospital setting and what it all means for your practice and patients. Additionally, they are joined by Nancy who survived the earliest days of COVID-19 in the United States and will share her learning moments with the panel and learners.

Credit Expired

0.50 CE Credit(s)

Expires: February 10, 2023

Target Audience

This activity is intended for emergency medicine, hospital medicine, infectious disease, internal medicine, and pediatric clinicians (MD/NP/PA/Nurses) involved in the treatment of patients with severe COVID-19 infection.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Assess disease severity and implications in patients with COVID-19
Incorporate emergency use authorization status and available clinical trial data into the selection of treatment for patients hospitalized with COVID-19
Integrate the unique roles and responsibilities of interprofessional care team members in the management of severe COVID-19 in hospitalized patients

Activity Faculty

Julia B. García-Díaz, MD, MSc, FACP, FIDSA, CPI

Director, Clinical Infectious Diseases Research and MultiSpecialties
Clinical Associate Professor, Medicine (Tulane University)
Associate Professor, University of Queensland/Ochsner Clinical School, Brisbane, Australia
Ochsner Health
New Orleans, LA

Thomas F. Patterson, MD, FACP, FIDSA

Chief, Division of Infectious Diseases
Vice-Chair, Faculty Development
Professor, Medicine
Director, San Antonio Center for Medical Mycology
UT Health San Antonio
San Antonio, TX

Fiona A. Winterbottom, DNP, MSN, APRN, ACNS-BC, ACHPN, CCRN

Advanced Practice Provider, Pulmonary Critical Care
Chairperson, System Critical Care Integration Council
Ochsner Medical Center
Ochsner Health
New Orleans, LA

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 